Clinical trial
Trafficking of Indium-III-Labeled Cultured Immune Cells in Patients Undergoing…
NCT00026897 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00026897 |
|---|---|
| Title | Trafficking of Indium-III-Labeled Cultured Immune Cells in Patients Undergoing Immunotherapy for Advanced Cancer |
| Official title | Trafficking of Indium-111-Labeled Cultured Immune Cells in Patients Undergoing Immunotherapy for Advanced Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neoplasm |
| Intervention type | Procedure |
| Interventions | Gamma-camera imaging, Low-risk biopsy |
| Enrollment | 100 |
| Start date | Dec 1, 1997 |
| Completion | Dec 1, 2002 |
| First posted | Nov 15, 2001 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: